Investing Ideas
/
Egyptian Pharmaceuticals & Biotech Sustainable Track Record

Egyptian Pharmaceuticals & Biotech Sustainable Track Record

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.

3 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
MPCI Memphis Pharmaceuticals & Chemical Industries	ج.م60.55	19.0%	-23.7%	ج.م340.6m	n/a	PE1.1x	n/a	6.6%
CPCI Kahira Pharmaceuticals & Chemical Industries	ج.م109.67	14.2%	76.1%	ج.م1.6b	n/a	PE6.7x	n/a	11.7%
PHAR Egyptian International Pharmaceutical Industries	ج.م45.84	-0.5%	16.9%	ج.م6.8b	ج.م77.62	PE5.9x	E21.7%	2.2%

Page 1 of 1